Crinetics Pharmaceuticals Inc (CRNX)
44.79
+1.32
(+3.04%)
USD |
NASDAQ |
Jun 28, 16:00
44.71
-0.08
(-0.18%)
After-Hours: 20:00
Crinetics Pharmaceuticals Cash from Investing (Quarterly): 0.309M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.309M |
| December 31, 2023 | -87.31M |
| September 30, 2023 | -193.30M |
| June 30, 2023 | 31.44M |
| March 31, 2023 | 48.76M |
| December 31, 2022 | 36.85M |
| September 30, 2022 | 6.822M |
| June 30, 2022 | -174.27M |
| March 31, 2022 | -43.38M |
| December 31, 2021 | -101.80M |
| September 30, 2021 | -7.025M |
| June 30, 2021 | 19.84M |
| March 31, 2021 | 32.50M |
| December 31, 2020 | -8.892M |
| September 30, 2020 | -24.83M |
| Date | Value |
|---|---|
| June 30, 2020 | 17.60M |
| March 31, 2020 | 16.34M |
| December 31, 2019 | -12.82M |
| September 30, 2019 | 20.45M |
| June 30, 2019 | 9.443M |
| March 31, 2019 | 24.60M |
| December 31, 2018 | -118.68M |
| September 30, 2018 | -0.251M |
| June 30, 2018 | -0.469M |
| March 31, 2018 | -0.057M |
| December 31, 2017 | -0.231M |
| September 30, 2017 | -0.018M |
| June 30, 2017 | -0.035M |
| March 31, 2017 | -0.02M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-193.30M
Minimum
Sep 2023
48.76M
Maximum
Mar 2023
-20.66M
Average
3.566M
Median
Cash from Investing (Quarterly) Benchmarks
| Syndax Pharmaceuticals Inc | -99.40M |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 1.00M |
| Theriva Biologics Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -52.86M |
| Cash from Financing (Quarterly) | 393.57M |
| Free Cash Flow | -184.45M |
| Free Cash Flow Per Share (Quarterly) | -0.7496 |
| Free Cash Flow to Equity (Quarterly) | -54.19M |
| Free Cash Flow Yield | -6.57% |